Clinical Trial Update: Implementing Precision Medicine Approaches to Guide Anti-platelet Selection [Phase 4]

View source ↗

Summary

Phase 4 trial update exploring precision medicine approaches to guide anti-platelet selection in acute coronary syndrome and MI settings.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Non-st-elevation Myocardial Infarction
• St-elevation Myocardial Infarction
• Unstable Angina

Snippet

Sponsor: University of Southern California | Conditions: Acute Coronary Syndrome (ACS), STEMI - ST Elevation Myocardial Infarction (MI) | Phase 4 | Status: UNKNOWN